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Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Spinal TB is associated with poor 
functional outcomes. Histopathological examination requires a long waiting times to obtain the results thus 
impractical for screening and may delay diagnosis. GeneXpert offers rapid tests for prompt screening and 
diagnosis. This study aimed to assess the diagnostic accuracy of GeneXpert in patients with spinal TB when 
compared to the histopathology test as the gold standard. This study was performed on patients in the Spine 
Clinic of the Department of Orthopedic and Traumatology, Dr. Hasan Sadikin General Hospital Bandung who were 
diagnosed with spinal TB during the period of May 2019–May 2020. Blood samples were collected from the 
patients and tested using GeneXpert and histopathological assessment. Results demonstrated 34 patients with a 
positive result and 6 patients with negative results on both diagnostic methods. Twenty nine out of 40 patients 
(72.5%) had rifampin-sensitive TB. Diagnostic accuracy of GeneXpert, when compared to histopathological 
examination, is represented by the sensitivity of 88.2%, specificity of 33.3%, positive predictive value of 88.2%, 
and negative predictive value of 33.3%. High sensitivity results forpatients with spinal TB on GeneXpert suggests 
that the test is appropriate to be used as a screening method and as a high-yield rapid diagnostic test for patients 
suspected for spinal TB.
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Perbandingan Akurasi Diagnosis antara GeneXpert dan Pemeriksaan 
Histopatologi pada Tuberkulosis Tulang Belakang
Abstrak
Tuberkulosis adalah penyakit menular yang disebabkan oleh kuman Mycobacterium tuberculosis. Terjadinya TB 
tulang belakang terkait dengan penurunan fungsi motorik dalam jangka panjang. GeneXpert merupakan alternatif 
metode diagnostik yang lebih cepat dari pemeriksaan dengan kultur. Penelitian ini bertujuan untuk menilai 
akurasi diagnosis GeneXpert terhadap pasien dengan TB tulang belakang dengan pemeriksaan histopatologi 
sebagai standar baku. Penelitian bertujuan membandingkan akurasi diagnosis GeneXpert terhadap pemeriksaan 
histopatologi pada pasien dengan TB tulang belakang. Pasien dengan diagnosis TB tulang belakang yang berobat 
ke poli tulang belakang Departemen Orthopaedi dan Traumatologi Rumah Sakit Dr. Hasan Sadikin Bandung pada 
Mei 2019–Mei 2020 merupakan kriteria inklusi pasien. Pengambilan sampel darah dilakukan untuk pemeriksaan 
GeneXpert dan histopatologi. Terdapat 34 pasien dengan hasil positif dan 6 pasien dengan hasil negatif pada 
pemeriksaan GenXpert dan histopatologi. Terdapat 29 dari 40 pasien (72,5%) yang sensitif terhadap rifampin. 
Akurasi diagnostik GeneXpert (dibanding dengan pemeriksaan histopatologi): sensitivitas 88,2%; spesifisitas 
33,3%; nilai prediktif positif 88,2%; dan nilai prediktif negatif 33,3%. Sensitivitas pemeriksaan yang tinggi 
pada pasien dengan TB tulang belakang menggunakan GeneXpert merupakan salah satu tanda bahwa metode 
diagnostik tersebut dapat digunakan sebagai alat skrining untuk diagnosis yang lebih cepat.
Kata kunci: Diagnostik, histopatologi, GeneXpert, spondilitis TB
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Introduction
Tuberculosis is a disease caused by the infection 
of Mycobacterium tuberculosis. Systemic and 
non-specific symptoms may be noted among TB 
patients, such as reduced appetite, unintentional 
weight loss, night sweats, fatigue, and chronic 
fever.1 This disease remains a prevalent problem 
worldwide. In 2016 alone, the prevalence rate 
of tuberculosis infection was 10.4 million, with 
an incidence rate of up to 120 cases per 100,000 
individuals worldwide in the same year, making 
it the 10th leading cause of death of the year.2in 
2010 there were 8.8 million new cases of 
tuberculosis (TB).
Despite the availability of effective TB 
treatment regimens, infection remains a 
prevalent problem. High caseloads were found 
particularly in the Southeast Asia region and 
Indonesia was in 5th place in TB prevalence 
rate in 2013, according to the World Health 
Organization (WHO).3 While tuberculosis 
infections are mainly confined to the pulmonary 
spaces, approximately a quarter of the cases may 
spread systematically. Such cases are defined as 
extrapulmonary TB.4 Data from the Department 
of Orthopaedics and Traumatology, Dr. Hasan 
Sadikin General Hospital Bandung, Indonesia, 
show that there are isolated cases of spinal TB 
infection without a previous history of lung TB 
infection. The department recorded 240 cases 
of spinal TB, with 80 cases required surgical 
management during the period of January 2014–
December 2018.5,6
Spinal TB cases are associated with higher 
rates of morbidity. Kyphotic deformities may 
occur in cases of spinal TB due to bone destruction 
of the vertebra. Sensory and motor deficits have 
been seen in 77.1% of cases of spinal TB. In 
severe cases, surgery is required to treat severe 
deformities, severe neurological deficits, and/
or to treat patients with paravertebral abscess.7 
To prevent further complications associated 
with TB infection, early diagnosis which leads to 
early treatment is paramount to prevent further 
spread. 
Confirmatory diagnosis of TB using culture 
from sputum sample is notably unsuitable for 
rapid screening. The primary limitation of the 
diagnostic method is the time needed to get the 
result, despite of its confirmatory nature. It may 
require weeks to get the result and to completely 
confirm the diagnosis. As such, other alternative 
methods are developed to reduce the time 
needed to diagnose this disease. 
One of these alternative method is the 
GeneXpert. GeneXpert is a rapid molecular test 
designed to provide semi-quantitative results in 
TB diagnosis, offering faster diagnostic results 
without any significant sacrifice to the diagnostic 
accuracy. The high throughput of GeneXpert, 
without significantly sacrificing diagnostic 
accuracy, is the primary advantage of GeneExpert 
compared to the previous gold standard. 
This study aimed to compare the diagnostic 
accuracy of GeneXpert to the histopathological 
examination in diagnosing spinal TB cases in 
Indonesia.
Methods
A cross-sectional study was conducted in Dr. 
Hasan Sadikin General Hospital Bandung, 
Indonesia. This study included patients with a 
previous spinal TB diagnosis with a confirmatory 
diagnosis of TB infection using histopathological 
examination and GeneXpert. Retrospective 
analysis of adult patients (15–65 years old) 
diagnosed with spinal TB and/or paravertebral 
abscess in this hospital from February 2020–
May 2020 was included herein. Patients with 
relapsed spinal TB and without paravertebral 
abscess were excluded from the study. The Ethical 
Committee of Dr. Hasan Sadikin General Hospital 
approved the study before its commencement 
with the issuance of the ethical clearance number 
LB.02.01/X.65/95/2020.
Variables collected from the study were 
acquired retrospectively from medical records 
on patients receiving spinal surgery for spinal 
TB and paravertebral abscess. Then, informed 
consent before the surgery and usage of pus 
samples (obtained intra-operatively) were 
obtained. Abscess drainage was performed 
during the surgery. Subsequently, the samples 
obtained were sent to the laboratory for 
GeneXpert and histopathological examination. 
The examination results using each method were 
then stratified according to the results (positive 
or negative).
Normality tests and differences of both 
diagnostic methods were applied to identify any 
significant differences between both methods. 
The Shapiro-Wilk normality test was used to 
determine the normality of numeric variables 
of the study. Numerical data with non-normal 
distribution were described in median and 
numerical data with normal distribution were 
described in mean and range. The chi-square test 
was used to compare the significant difference 
between the positive diagnosis in both methods 
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GeneXpert 2 (50.0%) 1 (2.8%) 3 (5.0%) 0.001
Positive 2 (50.0%) 35 (97.2%) 37 (92.5%)
Negative 4 (100.0%) 36 (90.0%) 40 (100%)
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with a p-value of <0.05 was deemed significant.
Results
Forty patients were included in the study with 
most of them were in the age group of 30–39 
years old (27.5%), followed by 40–49 years old 
(22.5%) and over 60 years old (22.5%) with the 
mean age of 47.45 years old. There were 26 male 
patients (65%) and 14 female patients (35%) 
included in this study, and 29 patients (72.5%) 
sufferred from rifampin-sensitive TB, according 
to the medical records.
Patients included in the study had received 
diagnosis based on both histopathological 
and GeneXpert testing. In comparison with 
histopathology examination, GeneXpert 
examination had a significantly higher positive 
diagnosis compared to the histopathology 
results (p=0.001). The diagnostic accuracy of 
GeneXpert, when compared to the histopathology 
examination as the gold standard, was as follows: 
sensitivity 88.2%, specificity 33.3%, positive 
predictive value 88.2%, and negative predictive 
value 33.3%. Sensitivity and positive predictive 
value for GeneXpert examination were high in 
the detection of patients with spinal tuberculosis.
Discussion
GeneXpert is a rapid diagnostic method for TB 
infections. The test was developed as a response 
to alleviate the main weakness of diagnostic 
confirmation using culture samples, which 
is time constraint. Increased prevalence and 
incidence of TB cases, despite the availability 
of antituberculosis drugs and regimens in 
developing countries, require rapid diagnostic 
methods to be developed to aid the management 
and prevention of the further spread of TB. 
This is particularly important in low-resource 
settings often faced in developing countries.8 
GeneXpert, as a screening tool, has sufficiently 
high sensitivity concerning its rapidity to 
generate test results. A previous study by Norin 
et al. had noted the following for the diagnostic 
accuracy parameters in GeneXpert for detection 
of M. tuberculosis: sensitivity 79.6%, specificity 
97.1%, positive predictive value 88%, and 
negative predictive value 94.6%. In cases of 
extrapulmonary TB, the diagnostic accuracy of 
GeneXpert may be relatively reduced. In the same 
study, a reduction of sensitivity to 60% and a 
positive predictive value of 60% were noted. The 
specificity and negative predictive value of the 
test increase to 95.4% and 95.4%, respectively.9 
Similar results were discovered herein when 
compared to the study above. It is possible 
that, due to the study’s limitation, decreased 
specificity and negative predictive value found in 
this study are due to the low number of samples 
collected for the study.
Despite its relatively high sensitivity and 
suitability in the screening tool, GeneXpert has 
a risk of increased overestimation in regions 
with low TB incidence.7,10 Additionally, for 
extrapulmonary TB cases, such as in South 
Africa, this method has been reported to have 
lower sensitivity yet with higher specificity. The 
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study in South Africa presumed the possibility of 
sample contamination that may lead to altered 
accuracy of the test in comparison to the samples 
diagnosed using culture samples.11 There are 
also several previous studies on GeneXpert 
diagnostic accuracy in diagnosing patients with 
spinal TB that have ben conducted. A previous 
study by Held et al. reported a high level of 
sensitivity (95.6%) and specificity (96.2%), with 
drastically faster diagnostic results. GeneXpert 
diagnostic results can be attained in 2 days, 
while the median time to diagnosis in culture 
studies is 35 days (interquartile range of 15–42 
days).12 Previous studies analyzing the accuracy 
of GeneXpert in the diagnosis of spinal TB have 
shown mixed results. Regardless, the present 
study’s results demonstrate high sensitivity and 
positive predictive value, yet with low specificity 
and negative predictive value. 
This study has several limitations. In 
comparison to previous studies analyzing the 
diagnostic accuracy of GeneXpert and spinal 
TB, the current study has a lower sample size 
(40 patients). Also, the GeneXpert diagnostic 
method may detect damaged MTB, resulting in a 
risk for gaining false-positive results. Specifically, 
this study analyzes the diagnostic accuracy of 
GeneXpert with a blood sample from patients 
with spinal TB. Blood culture samples are known 
to be less accurate compared to sputum samples. 
However, despite this limitation, this study is 
one of the few studies in Indonesia specifically 
addressing the usability of GeneXpert in 
diagnosing extrapulmonary TB cases with a 
specific focus on spinal TB. Future studies, 
preferably with further follow-ups, are required 
to further elucidate the function and feasibility 
of GeneXpert in diagnosing extrapulmonary TB 
in Indonesia. In conclusion, GeneXpert should 
be utilized as a diagnostic tool to screen and 
detect patients with spinal TB. Further studies 
may be required to assess the feasibility of rapid 
molecular testing methods in low-resource and 
high-incidence regions, specifically in Indonesia.
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